Evidence map›Paper›PMID 30504808›Full record

ArticleScientific reports2018

Alpha-tubulin acetyltransferase/MEC-17 regulates cancer cell migration and invasion through epithelial-mesenchymal transition suppression and cell polarity disruption.

Cheng-Che Lee, Yun-Ching Cheng, Chi-Yen Chang, Chi-Min Lin, Jang-Yang Chang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Decoding Rho GTPase signalling networks in directed cell migration.Frontiers in cell and developmental biology · 2026
    Review
  5. Article
  6. Luminal acetylation of microtubules is not essential forMicrobial cell (Graz, Austria) · 2025
    Article
  7. Tubulin Acetylation: A Critical Regulator of Microtubule Function.Results and problems in cell differentiation · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Cheng-Che LeeCenter of Infectious Disease and Signaling Research, College of Medicine, National Cheng Kung University, Tainan, ROC, Taiwan.
Yun-Ching ChengDepartment of Medical Research, Chang Bing Show Chwan Memorial Hospital, Changhua, ROC, Taiwan.
Chi-Yen ChangNational Institute of Cancer Research, National Health Research Institutes, Tainan, ROC, Taiwan.
Chi-Min LinNational Institute of Cancer Research, National Health Research Institutes, Tainan, ROC, Taiwan.
Jang-Yang ChangCenter of Infectious Disease and Signaling Research, College of Medicine, National Cheng Kung University, Tainan, ROC, Taiwan. z10208083@email.ncku.edu.tw.
National Health Research Institutes · TWChang Bing Show Chwan Memorial Hospital · TWNational Cheng Kung University Hospital · TW

Funding

Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 103-2320-B-006-036-MY3Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 103-2325-B-400-012Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 104-2325-B-400 -002Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 105-2325-B-400-001Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 106-2314-B-006-076-MY3
6 · The paper itself

Abstract

MEC-17, a newly identified alpha-tubulin-N-acetyltransferase 1, serves as the major α-tubulin acetyltransferase to promote α-tubulin acetylation in vitro and in vivo. Alteration of α-tubulin acetylation may be involved in morphology regulation, cell migration, and tumour metastasis. However, MEC-17's role in cell physiology and its effect on epithelial-mesenchymal transition (EMT) and cell polarity remain elusive. In the present study, we characterized the overexpressed or downregulated cell models through gene targeting as MEC-17 gain- or loss-of-function. Overexpression of MEC-17 enhanced the cell spreading area, suppressed pseudopods formation in a three-dimensional (3D) culture system, and inhibited cancer cell migratory and invasive ability and tumour metastasis by orthotopic lung cancer animal model. Furthermore, morphological change and migration inhibition of cancer cells were accompanied by EMT repression, Golgi reorientation, and polarity disruption caused by alteration of cdc42 activity via a decrease in Rho-GAP, ARHGAP21. By contrast, a reduction in endogenous MEC-17 accelerated the pseudopods formation and EMT, and facilitated cell migration and invasion. These results demonstrated the crucial role of MEC-17 in the modulation of intrinsic cell morphogenesis, migration, and invasive function through regulation of EMT and cell polarity.

Indexed as

Cell PolarityEpithelial-Mesenchymal TransitionA549 CellsAcetylationAcetyltransferasesCell MovementHumansNeoplasm InvasivenessNeoplasm MetastasisPseudopodiaTubulinAcetyltransferasesalpha-tubulin acetylaseTubulin

Identifiers

PMID30504808
PMCPMC6269487
OpenAlexW2903333583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.